A new study shows that people taking semaglutide, the active ingredient in Ozempic and Wegovy, are more likely to develop an optic nerve issue that can lead to sudden vision loss that has no known treatment. Researchers stressed that more studies are needed to confirm the link between the medication and vision problems.
